Drug firms look to provide reassurance over Covid-19 vaccine safety
The chief executives of nine leading biopharma companies have moved to reassure the public over the development and testing procedures for Covid-19 vaccines.
Archives for September 8, 2020
AbbVie inks exclusive deal with I-Mab for cancer drug
AbbVie has boosted its immunotherapy pipeline in a global licensing deal with Chinese biotech, I-Mab, for its anti-CD47 monoclonal antibody, lemzoparlimab.